Browsing Tag
Goldman Sachs
153 posts
Goldman Sachs raises Robinhood (Nasdaq: HOOD) price target to $121 after record June trading volumes
Goldman Sachs raises its Robinhood price target to $121 as prediction markets revenue crosses $400 million annualized, just 18 months after launch.
July 5, 2026
Presidio closes $83m Canyon Creek acquisition as mature gas strategy enters Arkoma Basin
Presidio Production Company has used asset-backed debt and newly issued shares to acquire 55 producing Arkoma Basin wells. The deal could support a higher dividend, but it also tests whether financial engineering and operational optimisation can consistently overcome natural production declines.
July 5, 2026
Bending Spoons (BSP) debuts on Nasdaq, valuation more than doubles to $18.4bn
Bending Spoons debuts on Nasdaq at an $18.4 billion valuation before its stock pulls back sharply in the following session.
July 3, 2026
Nutrabolt picks banks for $1bn IPO as C4 Energy growth tests drink valuations
Nutrabolt’s planned U.S. IPO could give investors access to C4 Energy and Bloom Nutrition, but valuation will depend on brand durability, distribution economics and whether billion-dollar revenue can translate into sustainable profit.
July 1, 2026
AOL owner Bending Spoons (BSP) targets $19bn Nasdaq listing in July 1 debut
Bending Spoons (BSP) IPO prices June 30 at $26-28 for a $19B Nasdaq debut July 1. Full executive analysis of the Italian software rollup. Read inside.
June 30, 2026
Honeywell Aerospace (HONA) debuts on Nasdaq as HON completes 1-for-2 reverse split
Honeywell completes Aerospace spinoff June 29: HONA debuts on Nasdaq joining S&P 500, HON becomes Honeywell Technologies with a 1-for-2 reverse split.
June 30, 2026
Could Martin Marietta’s $13.5bn Lhoist deal reshape the U.S. lime market?
Martin Marietta’s $13.5 billion Lhoist deal expands MLM’s lime, limestone and industrial minerals platform, but leverage and dilution remain key risks.
June 29, 2026
Select Medical (NYSE: SEM) shareholders approve $3.9bn buyout as founder-led consortium nears takeover
Select Medical shareholders approve a $3.9bn founder-led buyout. Discover what the deal means for SEM investors, debt and hospital strategy after the vote!
June 27, 2026
Lime wants a $1.66bn valuation, but its IPO is also a balance-sheet rescue
Lime’s proposed Nasdaq IPO could raise nearly $181 million and convert much of its debt into equity, but investors must decide whether global micromobility has finally become a durable business.
June 26, 2026
Bending Spoons seeks $19bn valuation as $1.6bn Nasdaq IPO tests acquisition model
Bending Spoons seeks a $19 billion valuation in its $1.62 billion Nasdaq IPO. Discover how acquisitions, rapid growth and heavy debt shape the BSP story.
June 23, 2026